Table 1 Demographic data of the RPTNBD group in the present study
Number | Age | Sex | BMI | ASA score | Preoperative ENBD | Diagnosis |
|---|---|---|---|---|---|---|
1 | 78 | Male | 23.4 | III | No | Pancreatic head cancer |
2 | 56 | Male | 21.3 | II | No | Pancreatic head cancer |
3 | 82 | Male | 24.7 | III | No | Pancreatic head cancer |
4 | 66 | Male | 23.3 | II | Yes | CBD cancer |
5 | 36 | Male | 17.9 | II | No | Pancreatic head cancer |
6 | 77 | Female | 20.7 | II | Yes | CBD cancer |
7 | 53 | Male | 21.2 | II | No | Klatskin tumor |
8 | 75 | Male | 19.7 | III | Yes | Pancreatic head cancer |
9 | 60 | Male | 18.4 | III | Yes | Pancreatic head cancer |
10 | 78 | Female | 27.8 | II | No | Pancreatic head cancer |
11 | 68 | Male | 23.4 | II | No | Pancreatic head cancer |
12 | 72 | Female | 15.3 | II | Yes | Pancreatic head cancer |
13 | 60 | Male | 20.7 | II | No | Pancreatic head cancer |
14 | 71 | Male | 27.0 | II | Yes | AOV cancer |
15 | 72 | Male | 24.3 | II | No | CBD cancer |
16 | 57 | Female | 33.3 | III | No | Klatskin tumor |
17 | 68 | Male | 25.0 | III | No | CBD cancer |
18 | 76 | Female | 26.2 | II | No | AOV cancer |
19 | 58 | Male | 19.3 | II | Yes | Pancreatic head cancer |
20 | 54 | Female | 17.7 | III | No | Pancreatic head cancer |
21 | 59 | Male | 24.2 | II | No | CBD cancer |